Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Does chronomodulated radiotherapy improve pathological response in locally advanced rectal cancer?

dc.contributor.authorSquire, Tim
dc.contributor.authorBuchanan, Grant
dc.contributor.authorRangiah, David
dc.contributor.authorDavis, Ian
dc.contributor.authorYip, Desmond
dc.contributor.authorChua, YuJo
dc.contributor.authorRich, Tyvin
dc.contributor.authorElsaleh, Hany
dc.date.accessioned2021-06-09T00:24:18Z
dc.date.issued2017
dc.date.updated2020-11-23T10:26:34Z
dc.description.abstractThe predominant mode of radiation-induced cell death for solid tumours is mitotic catastrophe, which is in part dependent on sublethal damage repair being complete at around 6 h. Circadian variation appears to play a role in normal cellular division, and this could influence tumour response of radiation treatment depending on the time of treatment delivery. We tested the hypothesis that radiation treatment later in the day may improve tumour response and nodal downstaging in rectal cancer patients treated neoadjuvantly with radiation therapy. Recruitment was by retrospective review of 267 rectal cancer patients treated neoadjuvantly in the Department of Radiation Oncology at the Canberra Hospital between January 2010 and November 2015. One hundred and fifty-five patients met the inclusion criteria for which demographic, pathological and imaging data were collected, as well as the time of day patients received treatment with each fraction of radiotherapy. Data analysis was performed using the Statistical Package R with nonparametric methods of significance for all tests set at p < 0.05. Of the 45 female and 110 male patients, the median age was 64. Seventy-three percent had cT3 disease and there was a mean tumour distance from the anal verge of 7 cm. Time to surgical resection following radiotherapy ranged from 4 to 162 days with a median of 50 days, with a complete pathological response seen in 21% of patients. Patients exhibiting a favourable pathological response had smaller median pre- and postradiotherapy tumour size and had a greater change in tumour size following treatment (p < 0.01). Patients who received the majority of their radiotherapy fractions after 12:00 pm were more likely to show a complete or moderate pathological response (p = 0.035) and improved nodal downstaging. There were also more favourable responses amongst patients with longer time to surgical resection postradiotherapy (p < 0.004), although no relationship was seen between response and tumour distance from the anal verge. Females were less likely to exhibit several of the above responses. Neoadjuvant radiotherapy for locally advanced rectal cancer performed later in the day coupled with a longer time period to surgical resection may improve pathological tumour response rates and nodal downstaging. A prospective study in chronomodulated radiotherapy in this disease is warranteden_AU
dc.format.mimetypeapplication/pdfen_AU
dc.identifier.issn0742-0528en_AU
dc.identifier.urihttp://hdl.handle.net/1885/236882
dc.language.isoen_AUen_AU
dc.publisherTaylor & Francisen_AU
dc.rights© 2017 Taylor & Francis Group, LLCen_AU
dc.sourceChronobiology Internationalen_AU
dc.subjectchemotherapyen_AU
dc.subjectchronomodulated therapyen_AU
dc.subjectpathological response. radiotherapyen_AU
dc.subjectrectal canceren_AU
dc.subjectsurgical resectionen_AU
dc.subjecttreatment timeen_AU
dc.titleDoes chronomodulated radiotherapy improve pathological response in locally advanced rectal cancer?en_AU
dc.typeJournal articleen_AU
local.bibliographicCitation.issue4en_AU
local.bibliographicCitation.lastpage503en_AU
local.bibliographicCitation.startpage492en_AU
local.contributor.affiliationSquire, Tim, University of Notre Dameen_AU
local.contributor.affiliationBuchanan, Grant, University of Adelaideen_AU
local.contributor.affiliationRangiah, David, College of Health and Medicine, ANUen_AU
local.contributor.affiliationDavis, Ian, College of Health and Medicine, ANUen_AU
local.contributor.affiliationYip, Desmond, College of Health and Medicine, ANUen_AU
local.contributor.affiliationChua, YuJo, College of Health and Medicine, ANUen_AU
local.contributor.affiliationRich, Tyvin, University of Virginia School of Medicineen_AU
local.contributor.affiliationElsaleh, Hany, College of Health and Medicine, ANUen_AU
local.contributor.authoruidRangiah, David, u5414824en_AU
local.contributor.authoruidDavis, Ian, u5095221en_AU
local.contributor.authoruidYip, Desmond, u5086006en_AU
local.contributor.authoruidChua, YuJo, u5101833en_AU
local.contributor.authoruidElsaleh, Hany, a225770en_AU
local.description.embargo2099-12-31
local.description.notesImported from ARIESen_AU
local.identifier.absfor111208 - Radiation Therapyen_AU
local.identifier.ariespublicationa383154xPUB5648en_AU
local.identifier.citationvolume34en_AU
local.identifier.doi10.1080/07420528.2017.1301462en_AU
local.identifier.scopusID2-s2.0-85016325550
local.identifier.thomsonID000399901900007
local.publisher.urlhttps://www.routledge.com/en_AU
local.type.statusPublished Versionen_AU

Downloads

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
01_Squire_Does_chronomodulated_2017.pdf
Size:
1.41 MB
Format:
Adobe Portable Document Format